These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16178920)

  • 1. CML clonal evolution with resistance to single agent imatinib therapy.
    Swords R; Quinn J; Fay M; O'Donnell R; Goldman J; Murphy PT
    Clin Lab Haematol; 2005 Oct; 27(5):347-9. PubMed ID: 16178920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clonal Ph-negative hematopoiesis with trisomy 8 in chronic myeloid leukemia during imatinib therapy].
    Yamamoto Y; Ishii K; Nomura S; Fukuhara S
    Rinsho Ketsueki; 2004 Feb; 45(2):164-6. PubMed ID: 15045827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
    Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
    Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression.
    Marktel S; Marin D; Foot N; Szydlo R; Bua M; Karadimitris A; De Melo VA; Kotzampaltiris P; Dazzi F; Rahemtulla A; Olavarria E; Apperley JF; Goldman JM
    Haematologica; 2003 Mar; 88(3):260-7. PubMed ID: 12651263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate in Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon alpha.
    Tóthová E; Kafková A; Fricová M; Benová B; Kirschnerová G; Tóthová A
    Neoplasma; 2005; 52(1):63-7. PubMed ID: 15739029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN; Pemberton P; Zonder J; Schiffer CA
    Clin Cancer Res; 2003 Apr; 9(4):1333-7. PubMed ID: 12684401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia.
    O'Brien SG; Deininger MW
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):26-30. PubMed ID: 12783372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).
    Patchenko P; Klepfish A; Trakhtenbrot L; Rothman R; Rachmilewitz EA
    Am J Hematol; 2004 Dec; 77(4):420. PubMed ID: 15558793
    [No Abstract]   [Full Text] [Related]  

  • 9. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
    O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
    Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia.
    Ghanima W; Kahrs J; Dahl TG; Tjonnfjord GE
    Eur J Haematol; 2004 Jun; 72(6):441-3. PubMed ID: 15128424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emergence and decrement of Ph-negative clone with trisomy 8 in CML during imatinib therapy].
    Kimura F; Kobayashi S; Ogura K; Kobayashi A; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Rinsho Ketsueki; 2004 Sep; 45(9):1058-60. PubMed ID: 15510836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: rationale and design of phase I/II trials.
    Guilhot F; Gardembas M; Rousselot P; Tulliez M; Vigier M; Buzyn A; Rigal-Huguet F; Legros L; Michallet M; Berthou C; Najman A; Maloisel F; Mahon FX; Facon T; Berthaud P; Guilhot J;
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):92-7. PubMed ID: 12783382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia.
    Yamamoto M; Kakihana K; Kurosu T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2005 Mar; 157(2):104-8. PubMed ID: 15721630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic studies in patients on imatinib.
    Deininger MW
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):50-5. PubMed ID: 12783376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib alone and in combination for chronic myeloid leukemia.
    Druker BJ
    Semin Hematol; 2003 Jan; 40(1):50-8. PubMed ID: 12563611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
    Terre C; Eclache V; Rousselot P; Imbert M; Charrin C; Gervais C; Mozziconacci MJ; Maarek O; Mossafa H; Auger N; Dastugue N; Talmant P; Van den Akker J; Leonard C; N'Guyen Khac F; Mugneret F; Viguié F; Lafage-Pochitaloff M; Bastie JN; Roux GL; Nicolini F; Maloisel F; Vey N; Laurent G; Recher C; Vigier M; Yacouben Y; Giraudier S; Vernant JP; Salles B; Roussi J; Castaigne S; Leymarie V; Flandrin G; Lessard M;
    Leukemia; 2004 Aug; 18(8):1340-6. PubMed ID: 15190256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
    Reed SD; Anstrom KJ; Ludmer JA; Glendenning GA; Schulman KA
    Cancer; 2004 Dec; 101(11):2574-83. PubMed ID: 15493042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment.
    Kim YJ; Kim DW; Lee S; Kim YL; Hwang JY; Park YH; Kim HJ; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2004 Jan; 33(2):237-42. PubMed ID: 14628081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib.
    Avery S; Nadal E; Marin D; Olavarria E; Kaeda J; Vulliamy T; Brito Babapulle F; Goldman JM; Apperley JF
    Leuk Res; 2004 May; 28 Suppl 1():S75-7. PubMed ID: 15036946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
    Anstrom KJ; Reed SD; Allen AS; Glendenning GA; Schulman KA
    Cancer; 2004 Dec; 101(11):2584-92. PubMed ID: 15493041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.